Marine Polymer Technologies, Inc.

Marine Polymer Technologies, Inc. (MPT) is a medical device company specializing in advanced biomaterials for hemostasis, wound healing, and severe bleeding control. Founded in 1992, the company develops proprietary products engineered from poly-N-acetyl glucosamine fibers derived from microalgae. The company's primary product lines include SyvekExcel® for vascular catheterization hemostasis, Talymed® for chronic and acute wound management (diabetic foot ulcers, venous leg ulcers, pressure wounds), and mrdh® for rapid severe bleeding control, including use in coagulopathic patients. MPT's solutions are designed for high reproducibility and safety across surgical, interventional, and wound care settings. Talymed® has received Medicare Pass-Through Status designation, indicating recognition of clinical significance. The company serves acute care hospitals, interventional radiology centers, wound care clinics, and surgical facilities. Manufacturing capabilities center on proprietary fiber technology and hemostatic/dressing product assembly. Products are indicated for healthcare provider and patient use across multiple procedure types and patient populations.